Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-11-000011
Filing Date
2011-01-10
Accepted
2011-01-10 15:03:33
Documents
1
Group Members
BAM OPPORTUNITY FUND SPV, LLCHAL MINTZROSS BERMAN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT - OXIGENE, INC. bam_13goxigene.htm SC 13G/A 131995
  Complete submission text file 0000929638-11-000011.txt   133991
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Subject) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45691 | Film No.: 11519986
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005
Business Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005 646-307-4503
BAM Management LLC (Filed by) CIK: 0001463541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A